Pharmacogenetics of dabigatran and apixaban in association with gastrointestinal bleeding.
In both dabigatran- and apixaban-treated patients, no associations between the selected polymorphisms and gastrointestinal bleeding risk were found, however the results should be interpreted with caution because of the small cohort size.
Authors
- Martin Beránek (ORCID: https://orcid.org/0000-0002-7422-722X)
- Eva Čermáková (ORCID: https://orcid.org/0000-0003-3413-4149)
- Ilja Tachecí (ORCID: https://orcid.org/0000-0003-3583-2651)
- Radován Malý (ORCID: https://orcid.org/0000-0002-9199-7883)
- Tomáš Veleta
- Petr Ďulíček (ORCID: https://orcid.org/0000-0002-4899-760X)
- T. Soukup (ORCID: https://orcid.org/0000-0003-2628-9183)
Institutions
- Charles University (CZ)
- University Hospital Hradec Králové (CZ)
Publication Details
- Journal
- PubMed
- Published
- 2024-11-28
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.39